GSK position history
The shares of GSK that KAHN BROTHERS GROUP INC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 659,872 shares, $25M, 5.1% of portfolio, New
- 2025 Q3: 260,837 shares, $11M, 2.1% of portfolio, Reduce −60.5%
- 2025 Q4: 178,696 shares, $8.8M, 1.6% of portfolio, Reduce −31.5%
- 2026 Q1: 160,982 shares, $8.9M, 1.6% of portfolio, Reduce −9.9%
- 2026 Q2: 158,438 shares, $8.3M, 1.3% of portfolio, Reduce −1.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|